Invesco Nasdaq Biotechnology ETF (IBBQ)
- Expense ratio0.18%
- Net assets$113.9M
- Dividend yield1.15%
- 1-year return+38.28%
- Holdings246
IBBQ ETF price chart
IBBQ quote & trading statistics
IBBQ performance
Annual returns & drawdowns →- YTD+25.15%
- 1 year+38.28%
- 3 years+24.49%/yr
- 5 years+8.27%/yr
- 10 years0.00%/yr
- 1Y volatility
- 17.69%
- 3Y volatility
- 17.66%
- 3Y Sharpe ratio
- 0.98
Returns include reinvested distributions; 3-, 5- and 10-year figures are annualized.
IBBQ top 10 holdings
All holdings →| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | GILD | Gilead Sciences Inc | 8.65% |
| 2 | AMGN | Amgen Inc | 8.42% |
| 3 | VRTX | Vertex Pharmaceuticals Inc | 7.84% |
| 4 | REGN | Regeneron Pharmaceuticals Inc | 5.22% |
| 5 | MRNA | Moderna Inc | 5.20% |
| 6 | ILMN | Illumina Inc | 2.74% |
| 7 | RVMD | Revolution Medicines Inc | 2.62% |
| 8 | BIIB | Biogen Inc | 2.49% |
| 9 | ALNY | Alnylam Pharmaceuticals Inc | 2.08% |
| 10 | RPRX | Royalty Pharma Plc | 1.86% |
The top 10 holdings make up 47.1% of the fund (246 holdings in total). As of October 25, 2026.
About Invesco Nasdaq Biotechnology ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
IBBQ ETF FAQ
What is the IBBQ expense ratio?
Invesco Nasdaq Biotechnology ETF has a net expense ratio of 0.18%, or $18.00 a year for every $10,000 invested.
How much money is in IBBQ?
Invesco Nasdaq Biotechnology ETF has about $113.9M in net assets.
What are the top holdings of IBBQ?
The largest positions in IBBQ are Gilead Sciences Inc (8.65%), Amgen Inc (8.42%), Vertex Pharmaceuticals Inc (7.84%). The fund holds 246 securities in total.
How has IBBQ performed?
IBBQ returned +38.28% over the past year and +8.27% a year over the past five years, including reinvested distributions.
Does IBBQ pay dividends?
IBBQ has a dividend yield of 1.15%.
When was IBBQ launched?
Invesco Nasdaq Biotechnology ETF began trading on June 11, 2021.
ETFs similar to IBBQ
Funds that track the same index or whose top-10 holdings overlap most with IBBQ's. Overlap: shared top-10 weight as a share of the larger top-10 total of the two funds.
| Symbol | Fund | Overlap | Expense ratio | Net assets | 1-year return |
|---|---|---|---|---|---|
| IBBQ | Invesco Nasdaq Biotechnology ETF | — | 0.18% | $113.9M | +38.28% |
| IBB | iShares Biotechnology ETF | 84% | 0.46% | $10.73B | +33.96% |
| BIS | ProShares UltraShort Nasdaq Biotechnology | 68% | 0.96% | $1.9M | -48.12% |
| PBE | Invesco Dynamic Biotechnology & Genome ETF | 62% | 0.56% | $430.9M | +37.84% |
| BIB | ProShares Ultra Nasdaq Biotechnology | 59% | 0.95% | $94.8M | +73.77% |
| BBH | VanEck Biotech ETF | 56% | 0.33% | $502.0M | +39.42% |